NeuBase Therapeutics Inc (NBSE)
0.405
-0.01
(-1.72%)
USD |
NASDAQ |
May 03, 16:00
0.376
-0.03
(-7.16%)
After-Hours: 20:00
NeuBase Therapeutics Shareholders Equity (Quarterly): 9.137M for Sept. 30, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2023 | 9.137M |
June 30, 2023 | 11.25M |
March 31, 2023 | 14.45M |
December 31, 2022 | 18.22M |
September 30, 2022 | 23.19M |
June 30, 2022 | 30.31M |
March 31, 2022 | 38.16M |
December 31, 2021 | 47.13M |
September 30, 2021 | 54.07M |
June 30, 2021 | 60.28M |
March 31, 2021 | 23.94M |
December 31, 2020 | 28.52M |
September 30, 2020 | 31.29M |
June 30, 2020 | 34.68M |
March 31, 2020 | 3.989M |
December 31, 2019 | 7.028M |
September 30, 2019 | 10.03M |
June 30, 2019 | 7.941M |
March 31, 2019 | 9.007M |
December 31, 2018 | 10.08M |
September 30, 2018 | -0.0419M |
June 30, 2018 | 17.18M |
March 31, 2018 | 17.66M |
December 31, 2017 | 19.68M |
September 30, 2017 | 22.84M |
Date | Value |
---|---|
June 30, 2017 | 27.97M |
March 31, 2017 | 18.62M |
December 31, 2016 | 25.84M |
September 30, 2016 | 24.96M |
June 30, 2016 | 29.02M |
March 31, 2016 | 35.58M |
December 31, 2015 | 38.87M |
September 30, 2015 | 42.49M |
June 30, 2015 | 45.59M |
March 31, 2015 | 48.16M |
December 31, 2014 | 22.61M |
September 30, 2014 | 26.75M |
June 30, 2014 | 28.79M |
March 31, 2014 | 3.327M |
December 31, 2013 | 4.339M |
September 30, 2013 | 5.264M |
June 30, 2013 | 6.608M |
March 31, 2013 | 2.279M |
December 31, 2012 | 0.5402M |
September 30, 2012 | 2.426M |
June 30, 2012 | 0.177M |
March 31, 2012 | -0.694M |
December 31, 2011 | -3.452M |
September 30, 2011 | -4.782M |
June 30, 2011 | -3.534M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
3.989M
Minimum
Mar 2020
60.28M
Maximum
Jun 2021
25.20M
Average
23.56M
Median
Shareholders Equity (Quarterly) Benchmarks
Ampio Pharmaceuticals Inc | 3.36M |
Stoke Therapeutics Inc | 159.56M |
ABVC BioPharma Inc | 8.388M |
MAIA Biotechnology Inc | 0.4775M |
Aprea Therapeutics Inc | 16.95M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 18.62M |
Total Liabilities (Quarterly) | 9.485M |